FDA Approves First Treatment for MCT8 Deficiency

发生了什么

The U.S. Food and Drug Administration today approved Emcitate (tiratricol) tablets for oral suspension to treat peripheral thyrotoxicosis (excess thyroid hormone levels in the blood that causes symptoms, such as rapid heart rate, increased blood pressure and adverse effects on metabolism) in patient

摘要按规则整理自下方来源原文

来源